Intrinsic Value

IGNT latest financial reports are more than 9 years old.
IGNT doesn't have a meaningful market cap.
Not Available for IGNT

There is not enough data to reliably calculate the intrinsic value for Ingen Technologies Inc.

Do our valuations actually work? See backtest results .

Alternatives to IGNT

Fundamental Analysis

What Ingen Technologies Does

Health Care

Ingen Technologies, Inc. engages in the manufacture of respiratory medical devices. The company is headquartered in Riverside, California. The company went IPO on 2001-07-11. The firm holds the manufacturing and marketing platforms to produce its core medical product line, referred to as Oxyview and Smart Nasal Cannula. The firm develops products for the treatment of chronic obstructive pulmonary disease (COPD), such as chronic bronchitis, emphysema and asthmatic bronchitis, all of which obstruct airflow from the lungs.

Headquarters
United States of America US
IPO date
Jul 11, 2001
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Ingen Technologies Inc

Wall St Price Targets

Capital Returns

Competitive Landscape